Lower Cost, Better Results, World Renowned Doctor.

Infertile patients cannot afford to wait for treatment while their eggs get older.

Dr. Sherman Silber, Infertility Center of St. Louis, is offering video consultations for patients who need to plan now for their treatment while stay-at-home orders are in place. He is talking to and evaluating patients in their home to comply with social distancing measures.

Dr. Silber is discovering that patients actually prefer this method of telemedicine consultation over the conventional office visit. Patients have conveyed that “it is so much more convenient and less stressful” to have a telemedicine personal consultation than to take a day off from work to travel to the doctor’s office and sit with other nervous patients in the waiting room.

The COVID-19 pandemic is thus changing much of the way we will do things in the future, and for the better. “Our patients are surprisingly much happier with this approach. Of course, at some point we need to perform hands on treatment. But with this new manner of seeing patients, we can come to the right diagnosis and treatment plan for most patients more efficiently, quickly, and painlessly, with no loss of personal one-on-one communication.” This is a very welcome new era of telemedicine that has been forced on us by the current difficult times.

Secure IVF Storage: Introducing the tomorrow machine at Infertility Center of St. Louis

In this brief video, Dr Sherman Silber reassures patients that the Infertility Center of St. Louis offers the safest cryogenic storage available for embryos, eggs, sperm and ovarian tissue. Conventional IVF labs often rely on decades-old liquid-nitrogen tanks that open with simple lids; by contrast, Silber’s clinic uses an FDA-approved “tomorrow machine” that combines biometric security, multi-step identity confirmation and automated robotics.

The moment tissue enters storage, it is assigned a unique digital profile tied to the patient’s name and birth date. Access begins with iris recognition: staff cannot even open the vault without a positive eye scan that matches their authorized profile. Next, they must enter a secure password, followed by the patient-specific identifiers. Only after all credentials align will the system locate and eject the single tray that contains that patient’s specimens, submerged in liquid nitrogen at –196 °C. This design eliminates two critical risks—sample mix-ups and sample loss—because no human can touch or view another patient’s material during retrieval.

Dr Silber emphasizes that skilled embryologists still monitor every stage, providing an essential “human layer” of vigilance. Yet if a technician were ever to click the wrong file or mis-tabulate a label, the machine’s software would refuse to proceed, blocking errors before they occur. The vault also logs each interaction with time stamps and operator IDs, creating an immutable audit trail for FDA inspectors and future chain-of-custody verification.

Because this biometric, password-protected system remains the only cryostorage platform fully cleared by the U.S. Food and Drug Administration, Silber asserts that patients can entrust their reproductive cells with complete peace of mind—immune to publicity-driven fears, mechanical failures or human mistakes.